Tetsu Shinkai
Chigasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast Cancer.
Journal: Clinical pharmacology and therapeutics
Published: March 25, 2022
Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).
Journal: Japanese journal of clinical oncology
Published: September 18, 2020
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.
Journal: Translational lung cancer research
Published: July 18, 2020
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.
Journal: Investigational new drugs
Published: June 19, 2020
Portal Vein Thrombosis in a Patient with Hereditary Antithrombin Deficiency.
Journal: Internal medicine (Tokyo, Japan)
Published: February 26, 2019
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.
Journal: BMC cancer
Published: February 02, 2016
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.
Journal: Japanese journal of clinical oncology
Published: November 08, 2014
Awareness about medical expenses and certifications of eligibility for limited health insurance payments for chemotherapy among clinicians at the Ehime Cancer Care Network Priority Hospitals (Ehime Cancer Kyoten Hospitals)
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 12, 2014
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Journal: The Lancet. Oncology
Published: December 07, 2013
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
Journal: Cancer chemotherapy and pharmacology
Published: September 09, 2013
Quality of gastric cancer care in designated cancer care hospitals in Japan.
Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care
Published: June 06, 2013
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
Journal: Japanese journal of radiology
Published: January 14, 2012
Last Updated: 09/26/2026